Old Web
English
Sign In
Acemap
>
Paper
>
Use of rituximab for post-SCT EBV-PTLD: the final results of a retrospective EBMT study.
Use of rituximab for post-SCT EBV-PTLD: the final results of a retrospective EBMT study.
2012
Jan Styczynski
Lidia Gil
J.P. Donnelly
Per Ljungman
R Martino
S. Halkes
Koen Theunissen
J Maertens
Krzysztof Kałwak
P. Hubáček
Simona Sica
W.J.F.M. van der Velden
Hamdy Omar
Chiara Nozzoli
Franca Fagioli
Susanne Matthes
Miguel Angel Diaz
Maddalena Migliavacca
Adriana Balduzzi
M. Faraci
A. Tomaszewska R. de la Camara
A. van Biezen
Gloria Tridello
H. Einsele
Simone Cesaro
Keywords:
Rituximab
Immunology
Medicine
Oncology
Internal medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]